VHCP Management II »

89bio shares owned by VHCP Management II

Quarter-by-quarter ownership of 89bio (ETNB) shares owned by VHCP Management II from 13F filings

Historical chart of VHCP Management II investment in 89bio

Tip: Access up to 7 years of quarterly data

All positions including 89bio held by VHCP Management II consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 89bio by VHCP Management II

Quarter filed Position value Share count Share price at filing
2019-12-31 $1.1M 41k 26.29

More positions owned by VHCP Management II

10x Genomics Inc Cl A (TXG)
Axsome Therapeutics (AXSM)
Constellation Pharmceticls I
Biohaven Pharmaceutical Holding
Shockwave Med
Iveric Bio
Kalvista Pharmaceuticals (KALV)
Obseva Sa
Mersana Therapeutics (MRSN)
Spero Therapeutics (SPRO)
Relmada Therapeutics (RLMD)
Adverum Biotechnologies
Marinus Pharmaceuticals
Forty Seven
Milestone Pharmaceuticals (MIST)

View all positions for VHCP Management II

Top funds holding 89bio

RA Capital Management
Henderson Group
Suvretta Capital Management
BlackRock
BlackRock
BVF
Vanguard Group
Pictet Asset Management Holding SA
State Street Corporation
Westfield Capital Management Company
Citadel Advisors
Deep Track Capital
Geode Capital Management
Redmile Group
MPM Oncology Impact Management

View all funds holding 89bio